Senior Clinical Science Specialist, Rare Disease / Liver, Houston
Ipsen
Summary
The Senior Clinical Science Specialist is an advanced team member who demonstrates strong clinical expertise, commercial acumen, and account leadership. This role manages complex accounts, engages diverse stakeholders, and leverages data to drive strategic decisions and outcomes.
Job description
This role will be responsible for the Houston, TX territory which includes Houston proper and surrounding area, as south as Galveston, as east as Jasper/Kirbyville, and as north as Corrigan.
Main Responsibilities
- Achieve or exceed objectives associated with assigned brands, including sales, share, and other quantitative and qualitative KPIs
- Effectively and professionally navigate through complex multi-stakeholder organizations including integrated networks, hospitals and healthcare communities
- Manage the assigned geography and customer accounts efficiently, following principles of key physician/account prioritization, daily call reporting, and resource utilization
- Develop and maintain appropriate professional relationships with customers, guided by the best interests of patients, and bound by Ipsen policies and procedures
- Engage in in-depth conversations with physicians and other healthcare professionals based on approved resources and messages and consistent with the approved label(s)
- Collaborate closely with cross-functional team members to identify and resolve customer needs with a high sense of urgency
- Review and analyze market/customer data to support and execute strategic planning
Knowledge & Experience
- Eight years life-sciences experience, including at least five years in rare or specialty areas, and at least three years in specialty biopharma sales
- Ideal candidates have experience in GI and/or Hepatology
- Proven track record for consistently meeting or exceeding quantitative and qualitative targets
- Demonstrated understanding of the payer and clinical landscape, especially in specialty & rare diseases
- Proven patient centricity demonstrated by empathy, understanding and commitment to support patients
- Superior presentation, organization, administration, and written communication skills
- Market, Disease and Product Knowledge
Education / Certifications
- BA/BS is required
- MBA, MSc, Nursing and other advanced degrees are a plus
Language(s)
- Fluent in English
Requirements
- Eight years life-sciences experience
- At least five years in rare or specialty areas
- At least three years in specialty biopharma sales
- Experience in GI and/or Hepatology preferred
- Proven track record meeting or exceeding quantitative and qualitative targets
- Demonstrated understanding of the payer and clinical landscape, especially in specialty & rare diseases
- Proven patient centricity demonstrated by empathy, understanding and commitment to support patients
- Superior presentation, organization, administration, and written communication skills
- Market, Disease and Product Knowledge
- BA/BS required
- MBA, MSc, Nursing and other advanced degrees a plus
- Fluent in English
Benefits
- 401(k) with company contributions
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Spending Accounts
- Parental Leave
- Paid Time Off
- Discretionary Winter Shutdown
- Well-being Allowance
- Commuter Benefits
Company overview
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a global presence in over 40 countries. Founded in 1929 by Henri Beaufour, the company has evolved into a leading mid-size pharmaceutical firm specializing in three key therapeutic areas: oncology, rare diseases, and neuroscience. With approximately 5,300 employees worldwide, Ipsen operates as a publicly traded company on Euronext Paris while maintaining significant family ownership through the Beaufour family. The company's portfolio includes innovative treatments such as Cabometyx for advanced cancers, Dysport for neurological conditions, and Bylvay for rare liver diseases. Ipsen has established itself as one of the world's top 15 biopharmaceutical companies in oncology sales, with medicines registered in 88 countries and direct commercial operations in over 30 nations. The company maintains four global R&D hubs and three pharmaceutical development centers, investing significantly in research and development to advance transformative medicines for patients with limited treatment options.